 | • レポートコード：QYR9N7544 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、代謝バイオマーカー試験のグローバル市場について調査・分析したレポートで、種類別（分離技術、検出技術、その他）、用途別（創薬、栄養ゲノミクス、毒物学テスト、個別化医療、機能的ゲノミクス）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・代謝バイオマーカー試験の世界市場規模 ・主要企業別市場シェア ・代謝バイオマーカー試験の世界市場規模：種類別（分離技術、検出技術、その他） ・代謝バイオマーカー試験の世界市場規模：用途別（創薬、栄養ゲノミクス、毒物学テスト、個別化医療、機能的ゲノミクス） ・代謝バイオマーカー試験のアメリカ市場規模（種類別、用途別） ・代謝バイオマーカー試験のヨーロッパ市場規模（種類別、用途別） ・代謝バイオマーカー試験の中国市場規模（種類別、用途別） ・代謝バイオマーカー試験の日本市場規模（種類別、用途別） ・代謝バイオマーカー試験の東南アジア市場規模（種類別、用途別） ・代謝バイオマーカー試験のインド市場規模（種類別、用途別） ・代謝バイオマーカー試験の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・代謝バイオマーカー試験の世界市場予測（2019年-2025年） ・代謝バイオマーカー試験の地域別市場予測（2019年-2025年） ... |
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
In 2018, the global Metabolic Biomarker Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Metabolic Biomarker Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Biomarker Testing development in United States, Europe and China.
The key players covered in this study
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Market segment by Type, the product can be split into
Separation Techniques
Detection Techniques
Others
Market segment by Application, split into
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Metabolic Biomarker Testing status, future forecast, growth opportunity, key market and key players.
To present the Metabolic Biomarker Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Metabolic Biomarker Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metabolic Biomarker Testing Market Size Growth Rate by Type (2014-2025)
1.4.2 Separation Techniques
1.4.3 Detection Techniques
1.4.4 Others
1.5 Market by Application
1.5.1 Global Metabolic Biomarker Testing Market Share by Application (2014-2025)
1.5.2 Drug Discovery
1.5.3 Nutrigenomics
1.5.4 Toxicology Testing
1.5.5 Personalized Medicine
1.5.6 Functional Genomics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Metabolic Biomarker Testing Market Size
2.2 Metabolic Biomarker Testing Growth Trends by Regions
2.2.1 Metabolic Biomarker Testing Market Size by Regions (2014-2025)
2.2.2 Metabolic Biomarker Testing Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Metabolic Biomarker Testing Market Size by Manufacturers
3.1.1 Global Metabolic Biomarker Testing Revenue by Manufacturers (2014-2019)
3.1.2 Global Metabolic Biomarker Testing Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metabolic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.2 Metabolic Biomarker Testing Key Players Head office and Area Served
3.3 Key Players Metabolic Biomarker Testing Product/Solution/Service
3.4 Date of Enter into Metabolic Biomarker Testing Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Metabolic Biomarker Testing Market Size by Type (2014-2019)
4.2 Global Metabolic Biomarker Testing Market Size by Application (2014-2019)
5 United States
5.1 United States Metabolic Biomarker Testing Market Size (2014-2019)
5.2 Metabolic Biomarker Testing Key Players in United States
5.3 United States Metabolic Biomarker Testing Market Size by Type
5.4 United States Metabolic Biomarker Testing Market Size by Application
6 Europe
6.1 Europe Metabolic Biomarker Testing Market Size (2014-2019)
6.2 Metabolic Biomarker Testing Key Players in Europe
6.3 Europe Metabolic Biomarker Testing Market Size by Type
6.4 Europe Metabolic Biomarker Testing Market Size by Application
7 China
7.1 China Metabolic Biomarker Testing Market Size (2014-2019)
7.2 Metabolic Biomarker Testing Key Players in China
7.3 China Metabolic Biomarker Testing Market Size by Type
7.4 China Metabolic Biomarker Testing Market Size by Application
8 Japan
8.1 Japan Metabolic Biomarker Testing Market Size (2014-2019)
8.2 Metabolic Biomarker Testing Key Players in Japan
8.3 Japan Metabolic Biomarker Testing Market Size by Type
8.4 Japan Metabolic Biomarker Testing Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Metabolic Biomarker Testing Market Size (2014-2019)
9.2 Metabolic Biomarker Testing Key Players in Southeast Asia
9.3 Southeast Asia Metabolic Biomarker Testing Market Size by Type
9.4 Southeast Asia Metabolic Biomarker Testing Market Size by Application
10 India
10.1 India Metabolic Biomarker Testing Market Size (2014-2019)
10.2 Metabolic Biomarker Testing Key Players in India
10.3 India Metabolic Biomarker Testing Market Size by Type
10.4 India Metabolic Biomarker Testing Market Size by Application
11 Central & South America
11.1 Central & South America Metabolic Biomarker Testing Market Size (2014-2019)
11.2 Metabolic Biomarker Testing Key Players in Central & South America
11.3 Central & South America Metabolic Biomarker Testing Market Size by Type
11.4 Central & South America Metabolic Biomarker Testing Market Size by Application
12 International Players Profiles
12.1 Agilent Technologies
12.1.1 Agilent Technologies Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metabolic Biomarker Testing Introduction
12.1.4 Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.1.5 Agilent Technologies Recent Development
12.2 Bio-Rad Laboratories
12.2.1 Bio-Rad Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metabolic Biomarker Testing Introduction
12.2.4 Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.2.5 Bio-Rad Laboratories Recent Development
12.3 Bruker
12.3.1 Bruker Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metabolic Biomarker Testing Introduction
12.3.4 Bruker Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.3.5 Bruker Recent Development
12.4 Danaher
12.4.1 Danaher Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metabolic Biomarker Testing Introduction
12.4.4 Danaher Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.4.5 Danaher Recent Development
12.5 Waters Corporation
12.5.1 Waters Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metabolic Biomarker Testing Introduction
12.5.4 Waters Corporation Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.5.5 Waters Corporation Recent Development
12.6 Thermo Fisher Scientific
12.6.1 Thermo Fisher Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metabolic Biomarker Testing Introduction
12.6.4 Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.6.5 Thermo Fisher Scientific Recent Development
12.7 Biocrates Life Sciences
12.7.1 Biocrates Life Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metabolic Biomarker Testing Introduction
12.7.4 Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.7.5 Biocrates Life Sciences Recent Development
12.8 Human Metabolome Technologies
12.8.1 Human Metabolome Technologies Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metabolic Biomarker Testing Introduction
12.8.4 Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2014-2019)
12.8.5 Human Metabolome Technologies Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Metabolic Biomarker Testing Key Market Segments
Table Key Players Metabolic Biomarker Testing Covered
Table Global Metabolic Biomarker Testing Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metabolic Biomarker Testing Market Size Market Share by Type 2014-2025
Figure Separation Techniques Figures
Table Key Players of Separation Techniques
Figure Detection Techniques Figures
Table Key Players of Detection Techniques
Figure Others Figures
Table Key Players of Others
Table Global Metabolic Biomarker Testing Market Size Growth by Application 2014-2025 (Million US$)
Figure Drug Discovery Case Studies
Figure Nutrigenomics Case Studies
Figure Toxicology Testing Case Studies
Figure Personalized Medicine Case Studies
Figure Functional Genomics Case Studies
Figure Metabolic Biomarker Testing Report Years Considered
Table Global Metabolic Biomarker Testing Market Size 2014-2025 (Million US$)
Figure Global Metabolic Biomarker Testing Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metabolic Biomarker Testing Market Size by Regions 2014-2025 (Million US$)
Table Global Metabolic Biomarker Testing Market Size by Regions 2014-2019 (Million US$)
Table Global Metabolic Biomarker Testing Market Share by Regions 2014-2019
Figure Global Metabolic Biomarker Testing Market Share by Regions 2014-2019
Figure Global Metabolic Biomarker Testing Market Share by Regions 2019
Table Market Top Trends
Table Global Metabolic Biomarker Testing Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metabolic Biomarker Testing Market Share by Manufacturers (2014-2019)
Figure Global Metabolic Biomarker Testing Market Share by Manufacturers in 2018
Table Global Metabolic Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metabolic Biomarker Testing Product/Solution/Service
Table Date of Enter into Metabolic Biomarker Testing Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table Global Metabolic Biomarker Testing Market Size Share by Type (2014-2019)
Figure Global Metabolic Biomarker Testing Market Size Market Share by Type (2014-2019)
Table Global Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table Global Metabolic Biomarker Testing Market Size Share by Application (2014-2019)
Figure Global Metabolic Biomarker Testing Market Size Market Share by Application (2014-2019)
Figure Global Metabolic Biomarker Testing Revenue Market Share by Application in 2018
Figure United States Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table United States Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table United States Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table United States Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table United States Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table United States Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table United States Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure Europe Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table Europe Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table Europe Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table Europe Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table Europe Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table Europe Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table Europe Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure China Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table China Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table China Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table China Metabolic Biomarker Testing Market Size by Type (2014-20189) (Million US$)
Table China Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table China Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table China Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure Japan Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table Japan Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table Japan Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table Japan Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table Japan Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table Japan Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table Japan Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure Southeast Asia Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table Southeast Asia Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table Southeast Asia Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure India Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table India Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table India Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table India Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table India Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table India Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table India Metabolic Biomarker Testing Market Share by Application (2014-2019)
Figure Central & South America Metabolic Biomarker Testing Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metabolic Biomarker Testing Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metabolic Biomarker Testing Market Share (2018-2019)
Table Central & South America Metabolic Biomarker Testing Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metabolic Biomarker Testing Market Share by Type (2014-2019)
Table Central & South America Metabolic Biomarker Testing Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metabolic Biomarker Testing Market Share by Application (2014-2019)
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Metabolic Biomarker Testing Business (2014-2019) (Million US$)
Figure Agilent Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Agilent Technologies Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Bio-Rad Laboratories Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Bio-Rad Laboratories Recent Development
Table Bruker Company Details
Table Bruker Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Bruker Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Bruker Recent Development
Table Danaher Company Details
Table Danaher Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Danaher Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Danaher Recent Development
Table Waters Corporation Company Details
Table Waters Corporation Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Waters Corporation Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Waters Corporation Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Biocrates Life Sciences Company Details
Table Biocrates Life Sciences Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Biocrates Life Sciences Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Biocrates Life Sciences Recent Development
Table Human Metabolome Technologies Company Details
Table Human Metabolome Technologies Revenue in Metabolic Biomarker Testing Business (2014-2019)(Million US$)
Figure Human Metabolome Technologies Revenue Growth Rate in Metabolic Biomarker Testing Business (2014-2019)
Table Human Metabolome Technologies Recent Development
Table Global Metabolic Biomarker Testing Market Size by Regions (Million US$) 2019-2025
Figure Global Metabolic Biomarker Testing Market Size Share by Regions (2019-2025)
Figure Global Metabolic Biomarker Testing Market Size Share by Regions in 2025
Figure United States Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure China Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure India Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metabolic Biomarker Testing Market Size Forecast (2019-2025)(Million USD)
Table Global Metabolic Biomarker Testing Market Size by Product (2019-2025) (Million US$)
Figure Global Metabolic Biomarker Testing Market Size by Product (2019-2025)
Figure Global Metabolic Biomarker Testing Market Size by Product in 2025
Table Global Metabolic Biomarker Testing Market Size by Application (2019-2025) (Million US$)
Figure Global Metabolic Biomarker Testing Market Size by Application (2019-2025)
Figure Global Metabolic Biomarker Testing Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の試験管内毒性試験市場：市場規模・現状・予測 In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early st…- 世界の診断用バイオマーカー市場：市場規模・現状・予測 Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various pur…
- 世界のメタボロミクスバイオマーカー市場：市場規模・現状・予測 Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly…
- 世界の腫瘍バイオマーカー検査市場：市場規模・現状・予測 In 2018, the global Tumor Biomarker Test market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Tumor Biomarker Test status, future forecast, growth opportunity, key market and key players. The study …
- 世界の睡眠障害テスト市場：市場規模・現状・予測 Sleeping sickness is a disease caused by infection with the flagellate protozoan Trypanosoma brucei gambiense or the closely related subspecies T.brucei rhodesiense.Growing technological advancement in molecular and clinical microbiology techniques are expected to drive the sleeping sickness testing…